Table 3.
The recent developments of allergen immunotherapy
| Formulation | Allergen |
|---|---|
| Subcutaneous/sublingual | Recombinant |
| Epicutaneous | Purified |
| Intralymphatic | Bacteria-derived adjuvants |
| Micro-injection | DNA-derived adjuvants |
| Allergen peptides |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.